McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3026% above fair value
$1102.81+25.76 (+2.39%)
Close on Nov 13, 2026Market cap $128.58BP/E 28.4Yield 0.29%
McKesson enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
McKesson's enterprise value was $137.27B on Nov 11, 2026, against $114.83B a year earlier. Over the last 5 years it ranged from $43.60B to $137.27B, with a median of $77.13B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $137.27B | +28.1% |
| 2025 | Dec 31, 2025 | $107.19B | +36.7% |
| 2024 | Dec 31, 2024 | $78.41B | +16.9% |
| 2023 | Dec 29, 2023 | $67.10B | +14.5% |
| 2022 | Dec 30, 2022 | $58.60B | +34.4% |
| 2021 | Dec 31, 2021 | $43.60B | +26.7% |
| 2020 | Dec 31, 2020 | $34.42B | +3.4% |
| 2019 | Dec 31, 2019 | $33.30B | +12.2% |
| 2018 | Dec 31, 2018 | $29.69B | -24.8% |
| 2017 | Dec 29, 2017 | $39.47B | +12.6% |
| 2016 | Dec 30, 2016 | $35.05B | -30.6% |
| 2015 | Dec 31, 2015 | $50.51B | -11.0% |
| 2014 | Dec 31, 2014 | $56.73B | +39.9% |
| 2013 | Dec 31, 2013 | $40.54B | +61.6% |
| 2012 | Dec 31, 2012 | $25.09B | +25.7% |
| 2011 | Dec 30, 2011 | $19.96B | +9.0% |
| 2010 | Dec 31, 2010 | $18.30B | +11.5% |
| 2009 | Dec 31, 2009 | $16.42B | – |
See a number that looks wrong?